Lijun Wang

机构：Kunming University of Science and Technology, Chinese Center For Disease Control and Prevention, Sichuan University, West China Hospital of Sichuan University, Shaanxi Xueqian Normal University, The First Hospital of Kunming, First Affiliated Hospital of Xi'an Jiaotong University, Weihai Municipal Hospital, Changchun Institute of Technology, Changchun University of Technology, Shaanxi Normal University · ORCID：0000-0003-1306-7055

发表论文 122 篇 · 总被引 1912 次 · h-index 28

代表论文

• FTO protects human granulosa cells from chemotherapy-induced cytotoxicity (2022 · Reproductive Biology and Endocrinology · 被引 48)
• FGF2 Is Protective Towards Cisplatin-Induced KGN Cell Toxicity by Promoting FTO Expression and Autophagy (2022 · Frontiers in Endocrinology · 被引 39)
• Integrative bioinformatics analysis of WDHD1: a potential biomarker for pan-cancer prognosis, diagnosis, and immunotherapy (2023 · World Journal of Surgical Oncology · 被引 29)
• FGF2 promotes the proliferation of injured granulosa cells in premature ovarian failure via Hippo-YAP signaling pathway (2024 · Molecular and Cellular Endocrinology · 被引 13)
• Promotion of healthy adipose tissue remodeling ameliorates muscle inflammation in a mouse model of sarcopenic obesity (2023 · Frontiers in Nutrition · 被引 11)
• SAMSN1 causes sepsis immunosuppression by inducing macrophages to express coinhibitory molecules that cause T-cell exhaustion via KEAP1–NRF2 signaling (2025 · Chinese Medical Journal · 被引 8)